...
首页> 外文期刊>Folia medica >Microemulgel of Voriconazole: an Unfathomable Protection to Counter Fungal Contagiousness
【24h】

Microemulgel of Voriconazole: an Unfathomable Protection to Counter Fungal Contagiousness

机译:伏立康唑微乳:对抗真菌传染性的深不可测的保护。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Fluconazole and ketoconazole both have poor minimum inhibitory concentration than voriconazole. Voriconazole had serious side effects in oral and intravenous doses. It has poor water solubility. The objective of the study was to prepare and optimize microemulgel of voriconazole for topical delivery. Aim: Formulation, development, and evaluation of voriconazole microemulgel for topical delivery. Methods: Oil and emulsifi ers selected were on the basis of equilibrium solubility study and emulsification property respectively. The pseudo-ternary plot and constrained simplex lattice design were applied for preparation of microemulsions. Microemulsions were subjected to micelle size, zeta potential, polydispersity index, and in vitro study. They were optimized by Design-Expert? 9.0.3.1 software. Formulation, development, evaluation and optimization of microemulgel were carried out. Microbial assay of an optimized batch of microemulgel was performed. Results: Solubility of voriconazole in Parker Neem? oil was 7.51±0.14 mg/g. Acrysol?K-150: PEG-400 in 4:1 ratio had the highest area for microemulsion. 59.2% Acrysol?K-150, 14.8% PEG-400, 11% Parker Neem? oil, 15% rose water, and 1% voriconazole as an optimized batch of microemulsion was selected for preparation of microemulgel. Carbomer 934P found a good gelling agent in 0-2% w/w concentration. An optimized batch of microemulgel had 0.974 desirability value. An optimized batch of microemulgel and Nizral? cream had 37.32±0.63% and 26.45±0.63% zones of inhibition. Conclusion: Topical antifungal treatment was successfully achieved with voriconazole microemulgel.
机译:背景:氟康唑和酮康唑的最低抑菌浓度均低于伏立康唑。伏立康唑在口服和静脉内给药时有严重的副作用。它的水溶性差。该研究的目的是制备和优化伏立康唑微乳剂的局部给药。目的:伏立康唑微乳剂的局部给药配方,开发和评价。方法:在平衡溶解度研究和乳化性能的基础上,分别选择油和乳化剂。拟三元图和约束的单纯形晶格设计应用于微乳液的制备。对微乳液进行胶束大小,ζ电势,多分散指数和体外研究。它们是由设计专家优化的吗? 9.0.3.1软件。进行了微乳的配制,开发,评价和优化。对一批优化的微乳胶进行了微生物检测。结果:伏立康唑在帕克印em中的溶解度?油为7.51±0.14mg / g。比例为4:1的Acrysol?K-150:PEG-400具有最大的微乳液面积。 59.2%Acrysol®K-150、14.8%PEG-400、11%Parker Neem?选择了油,15%的玫瑰水和1%的伏立康唑作为微乳液的优化批次,用于制备微乳液。卡波姆934P在0-2%w / w的浓度下发现了良好的胶凝剂。优化的一批微乳胶具有0.974的期望值。优化的一批微乳胶和Nizral?乳膏具有37.32±0.63%和26.45±0.63%的抑制区。结论:伏立康唑微乳剂成功地实现了局部抗真菌治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号